跳至主要内容
临床试验/DRKS00021533
DRKS00021533已完成未知

Intestinal permeability in glomerular diseases

niversitätsklinikum der RWTH Aachen0 个研究点目标入组 62 人开始时间: 2020年4月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
62

研究概览

简要总结

The present single center pilot study suggests that disturbed intestinal permeability is common in patients with glomerular diseases and is not specific for IgAN.

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Biopsy-proven primary glomerulonephritis or no prior renal disease (healthy controls). Able to consent.

排除标准

  • History of chronic gastrointestinal diseases, signs of acute infection, diabetes mellitus, end-stage renal disease, or intake of non-steroidal anti-inflammatory drugs (NSAID) during the last 48 hours prior to the study as well as pregnant and breast-feeding patients

研究者

发起方
niversitätsklinikum der RWTH Aachen

相似试验

Intestinal permeability in glomerular diseases | 临床试验